FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif., December 22, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly ...
Zacks Investment Research on MSN
GILD exercises option to license Assembly Bio's herpes programs
Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences ...
Gilead (GILD) and Assembly Biosciences (ASMB), announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback